Vertex Pharmaceuticals (VRTX) Goodwill & Intangibles (2009 - 2026)

Vertex Pharmaceuticals' Goodwill & Intangibles history runs 18 years deep, the most recent figure standing at $1.5 billion for Q1 2026.

• In Q1 2026, Goodwill & Intangibles fell 1.48% year-over-year to $1.5 billion; the TTM figure through Mar 2026 stood at $1.5 billion (down 1.48% YoY), while the FY2025 annual figure was $1.5 billion, down 20.99% from the prior year.
• Goodwill & Intangibles for Q1 2026 stood at $1.5 billion, roughly flat from $1.5 billion in the prior quarter.
• The five-year high for Goodwill & Intangibles was $1.9 billion in Q4 2023, with the low at $1.4 billion in Q2 2022.
• The 5-year median for Goodwill & Intangibles is $1.7 billion (2022), against an average of $1.7 billion.
• The sharpest annual moves came in 2023 and 2025: Goodwill & Intangibles advanced 21.77% in 2023, then retreated 20.99% in 2025.
• Vertex Pharmaceuticals' Goodwill & Intangibles stood at $1.7 billion in 2022, then advanced by 14.68% to $1.9 billion in 2023, then slipped by 1.34% to $1.9 billion in 2024, then declined by 20.99% to $1.5 billion in 2025, then decreased by 0.38% to $1.5 billion in 2026.
• Business Quant data shows VRTX's Goodwill & Intangibles at $1.5 billion in Q1 2026, $1.5 billion in Q4 2025, and $1.5 billion in Q3 2025.